<?xml version="1.0" encoding="UTF-8"?>
<p id="Par7">As for COVID-19, numerous studies have described typical clinical manifestations including fever, cough, sore throat, shortness of breath, diarrhea, and fatigue. COVID-19 also has characteristic laboratory findings and lung computed tomography abnormalities [
 <xref ref-type="bibr" rid="CR9">9</xref>]. However, there is growing literature that patients with COVID-19 have cardiac [
 <xref ref-type="bibr" rid="CR10">10</xref>] and neuropsychiatric manifestations, as well. A recently published study that looked at 214 cases of severe coronavirus illness treated in Wuhan during the early phase of the global pandemic reported that about 36% of patients displayed neurological symptoms [
 <xref ref-type="bibr" rid="CR11">11</xref>]. This study reports that strokes, altered consciousness, and other neurological issues are relatively common in serious cases of COVID-19. These include both direct and indirect involvement of the nervous system. Following this study, there have been several case reports of various neurologic diagnoses. The reported manifestations include anosmia, ageusia, stroke, AIDP, acute necrotizing hemorrhagic encephalopathy, toxic–metabolic encephalopathy, headache, myalgia, central respiratory failure, myelitis, ataxia, and various neuropsychiatric manifestations.
</p>
